The transfection efficiency also matched previously reported B7H3 canine CAR T transduction efficiencies [39] though whereas the Zhang et al. study utilized blood from healthy dogs, our study used blood from dogs with sarcoma in order to more accurately reflect the clinical setting for autologous CAR T cell therapy. The gene discussed is CD276; the disease is sarcoma.